Colombel, J. F., Hanauer, S. B., Sandborn, W., Sands, B. E., Schreiber, S., Danese, S., Kierkus, J., Kulynych, R., Klopocka, M., Lahat, A., Gonciarz, M., Osipenko, M., Borzan, V., Kowalski, M., Saenko, D., Sardinov, R., Kim, S., Bae, Y., Lee, S., Yang, S., Lee, J., Lee, S. J., Lee, S. G., Park, G., & , (n.d.). dOP86 Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease: A phase 3, randomised, placebo-controlled study (LIBERTY-CD). Journal of Crohn's and colitis, 17, i161–i162. http://access.bl.uk/ark:/81055/vdc_100179843738.0x00003a